PirA or PirB binding nanobodies protect whiteleg shrimp from acute hepatopancreatic necrosis disease and replace antibiotics

By 2050, around 2 million people — the majority aged over 70 — could die from drug-resistant infections each year.

A showcase of how nanobodies can be harnessed for applications including neutralization of viruses and combating antibiotic-resistant bacte

Clostridium perfringens NetB and CnaA neutralizing nanobodies in feed can be used as preventative or curative alternatives to antibiotics.

This publication describes how nanobodies can be orally administered and discusses the benefits and strengths of this platform.